Cargando…
Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination
BACKGROUND: There are different factors that influence treatment outcome after ovarian stimulation and timed-intercourse or intrauterine insemination (IUI). After patient age, it has been suggested that timing of insemination in relation to ovulation is probably the most important variable affecting...
Autores principales: | Mitwally, Mohamed F, Abdel-Razeq, Sonya, Casper, Robert F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC479701/ https://www.ncbi.nlm.nih.gov/pubmed/15239837 http://dx.doi.org/10.1186/1477-7827-2-55 |
Ejemplares similares
-
Impact of Intrauterine Administration of Human Chorionic Gonadotropin before Intrauterine Insemination in Infertile Women: A Randomized Controlled Trial
por: Wadhwa, Leena, et al.
Publicado: (2021) -
Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022) -
The İmpact of Gonadotropin Type on Controlled Ovarian Stimulation and İntrauterine İnsemination Cycle Outcomes
por: Cicek, Ozge Senem Yucel, et al.
Publicado: (2022) -
Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016) -
Multiple Pregnancy after Gonadotropin-Intrauterine Insemination: An Unavoidable Event?
por: Fong, Shirley A., et al.
Publicado: (2011)